Johnson & Johnson: Hemorrhage trials

The registry lists 17 Hemorrhage studies with Johnson & Johnson as lead sponsor. 1 are open to participants now and 9 have results posted.

Phase 2 2Phase 3 6Phase 4 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study Comparing ETHICON™ 4000 Stapler System With Standard of Care Stapling Devices in Adults Undergoing Gastric and Thoracic ProceduresNot yet recruitingNCT07744568Not applicable
• The SURGICEL® Powder Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding (China Study)CompletedNCT03783039Not applicableResults posted
• SURGICEL® Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding in Adult SubjectsCompletedNCT03762200Not applicableResults posted
• The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding StudyCompletedNCT03255174Phase 3Results posted
• The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding StudyCompletedNCT02227992Phase 3Results posted
• The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding StudyCompletedNCT02227706Phase 3Results posted
• The Bioseal Vascular StudyCompletedNCT02094885Phase 4Results posted
• The EVARREST® Fibrin Sealant Patch Liver StudyCompletedNCT01993888Phase 3Results posted
• EVARREST™ Fibrin Sealant Patch Post-Market StudyCompletedNCT01902459Phase 4Results posted
• The Evicel Post-Authorization Surveillance StudyCompletedNCT01158261Results posted
• A Study of Severe Uterine Bleeding Following Exposure to Direct Oral AnticoagulantsCompletedNCT04394234
• A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and ImplicationsCompletedNCT02830178
• The Fibrin Pad Liver StudyCompletedNCT01166243Phase 3
• The Severe Soft Tissue Bleeding StudyCompletedNCT00977925Phase 3
• An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended RegimenCompletedNCT00344383Phase 2
• An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional RegimenCompletedNCT00320580Phase 2
• An Observational Study of Blood Management Techniques in Oncology Surgical TreatmentCompletedNCT00264095